Trade BNR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Burning Rock Biotech Limited American Depositary Shares (BNR) is trading at US$11.60, down 5.54% today as of Sep 14, 16:00 EDT. The company has a market capitalisation of US$103.14M. Over the past 52 weeks, BNR has traded between US$6.79 and US$41.72. On Syfe you can trade BNR with $0 commission and add it to your watchlist.
| Previous close | US$12.28 |
|---|---|
| Market cap | US$103.14M |
| 52-week range | US$6.79 – US$41.72 |
| Volume | 238.83K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Burning Rock Biotech Limited American Depositary Shares
Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The firm operates through the following segments: Central Laboratory Business, In-Hospital Business and Pharma Research and Development Services. Its products and clinical applications include companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction and tumor susceptibility tests. The company was founded by Yu Sheng Han in January 2014 and is headquartered in Guangzhou, China.
Year: 2020
Burning Rock Biotech Insider Bought Shares Worth $6,182,172, According to a Recent SEC Filing
Jul 2, 12:45 PM · MT Newswires
Burning Rock Biotech Insider Bought Shares Worth $5,466,143, According to a Recent SEC Filing
Apr 2, 11:21 AM · MT Newswires
Stay on top of BNR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
